Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA A Cancer J Clin. 2022;72(1):7–33.
Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017;168(4):707–23.
Article CAS PubMed PubMed Central Google Scholar
Wang D, Liu B, Zhang Z. Accelerating the understanding of cancer biology through the lens of genomics. Cell. 2023;186(8):1755–71.
Article CAS PubMed Google Scholar
Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, Wang Q, Li X, Zhang Y, Xu J. Molecular characterization and clinical relevance of m 6 a regulators across 33 cancer types. Mol Cancer. 2019;18:1–6.
Article PubMed PubMed Central Google Scholar
Zheng H, Wang M, Zhang S, Hu D, Yang Q, Chen M, Zhang X, Zhang Y, Dai J, Liou YC. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response. Int J Biol Sci. 2023;19(14):4689.
Article CAS PubMed PubMed Central Google Scholar
Essers PB, Pereboom TC, Goos YJ, Paridaen JT, MacInnes AW. A comparative study of nucleostemin family members in zebrafish reveals specific roles in ribosome biogenesis. Dev Biol. 2014;385(2):304–15.
Article CAS PubMed Google Scholar
Paridaen JTML, Janson E, Utami KH, Pereboom TC, Essers PB, van Rooijen C, Zivkovic D, MacInnes AW. The nucleolar GTP-binding proteins Gnl2 and nucleostemin are required for retinal neurogenesis in developing zebrafish. Dev Biol. 2011;355(2):286–301.
Article CAS PubMed Google Scholar
Datta D, Anbarasu K, Rajabather S, Priya RS, Desai P, Mahalingam S. Nucleolar GTP-binding protein-1 (NGP-1) promotes G1 to S phase transition by activating cyclin-dependent kinase inhibitor p21Cip1/Waf1. J Biol Chem. 2015;290(35):21536–52.
Article CAS PubMed PubMed Central Google Scholar
Iuchi S, Paulo JA. RNAmetasome network for macromolecule biogenesis in human cells. Commun Biol. 2021;4(1):1399.
Article CAS PubMed PubMed Central Google Scholar
De Angelis PM, Svendsrud DH, Kravik KL, Stokke T. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer. 2006;5(1):1–25.
Dong Y, Cai Q, Fu L, Liu H, Ma M, Wu X. Study of the G protein nucleolar 2 value in liver hepatocellular carcinoma treatment and prognosis. Biomed Res Int. 2021;2021:4873678.
Article PubMed PubMed Central Google Scholar
Nakamura K, Reid BM, Chen A, Chen Z, Goode EL, Permuth JB, Teer JK, Tyrer J, Yu X, Kanetsky PA. Functional analysis of the 1p34. 3 risk locus implicates GNL2 in high-grade serous ovarian cancer. Am J Hum Genet. 2022;109(1):116–35.
Article CAS PubMed Google Scholar
Wei S, Lu K, Xing J, Yu W. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. FASEB J. 2023;37(4):e22849.
Article CAS PubMed Google Scholar
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.
Article PubMed PubMed Central Google Scholar
Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z. CancerSEA: a cancer single-cell state atlas. Nucl Acid Res. 2019;47(D1):D900-8.
Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol. 2008;4(11):e1000217.
Article PubMed PubMed Central Google Scholar
Veres DV, Gyurkó DM, Thaler B, Szalay KZ, Fazekas D, Korcsmáros T, Csermely P. ComPPI: a cellular compartment-specific database for protein–protein interaction network analysis. Nucl Acid Res. 2015;43(D1):D485-93.
Dempster JM, Boyle I, Vazquez F, Root DE, Boehm JS, Hahn WC, Tsherniak A, McFarland JM. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 2021;22:1–23.
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2. 0 for analysis of tumor-infiltrating immune cells. Nucl Acid Res. 2020;48(W1):W509-14.
Qiu C, Shi W, Wu H, Zou S, Li J, Wang D, Liu G, Song Z, Xu X, Hu J, Geng H. Identification of molecular subtypes and a prognostic signature based on inflammation-related genes in colon adenocarcinoma. Front Immunol. 2021;12:769685.
Article CAS PubMed PubMed Central Google Scholar
Feng D, Zhu W, Shi X, Wang Z, Wei W, Wei Q, Yang L, Han P. Immune-related gene index predicts metastasis for prostate cancer patients undergoing radical radiotherapy. Exp Hematol Oncol. 2023;12(1):8.
Article CAS PubMed PubMed Central Google Scholar
Yi Q, Pu Y, Chao F, Bian P, Lv L. ACAP1 deficiency predicts inferior immunotherapy response in solid tumors. Cancers (Basel). 2022;14(23).
Hasan S. Effects of plyometric vs. strength training on strength, sprint, and functional performance in soccer players: a randomized controlled trial. Sci Rep. 2023;13(1):4256.
Article CAS PubMed PubMed Central Google Scholar
Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ. Comparative toxicogenomics database (CTD): update 2021. Nucl Acid Res. 2021;49(D1):D1138-43.
Liu CJ, Fe H, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.
Reinhold WC, Wilson K, Elloumi F, Bradwell KR, Ceribelli M, Varma S, Wang Y, Duveau D, Menon N, Trepel J. CellMinerCDB: NCATS is a web-based portal integrating public cancer cell line databases for pharmacogenomic explorations. Cancer Res. 2023;83(12):1941–52.
Article CAS PubMed PubMed Central Google Scholar
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J, Omberg L, Gevaert O. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338–54.
Article CAS PubMed PubMed Central Google Scholar
Yang C, Zhang H, Chen M, Wang S, Qian R, Zhang L, Huang X, Wang J, Liu Z, Qin W. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. Elife. 2022;11:e71880.
Article CAS PubMed PubMed Central Google Scholar
Sepulveda JL. Using R and bioconductor in clinical genomics and transcriptomics. J Mol Diagn. 2020;22(1):3–20.
Article CAS PubMed Google Scholar
Schober P, Vetter TR. Kaplan-Meier curves, log-rank tests, and cox regression for time-to-event data. Anesth Analgesia. 2021;132(4):969–70.
Duan J, Zhu L, Shi Y, Wang W, Wang T, Ning T, Zhang L, Bai M, Li H, Liu R. Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study. BMC Cancer. 2024;24(1):302.
Article CAS PubMed PubMed Central Google Scholar
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Yang T-HO, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA. The immune landscape of cancer. Immunity. 2018;48(4):812–30.
留言 (0)